Thought Leadership

The Federal Circuit Weighs in On Hatch-Waxman “Skinny” Label Infringement Dispute

USPTO Launches Semiconductor Technology Pilot Program

Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices

Amended FRE 702 on Expert Testimony Effective December 1, 2023

ITC Monthly Wrap-Up: November 2023

Minnesota Patent Litigation Wrap-Up: Q3 2023

ITC Monthly Wrap-Up: October 2023

FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs

EPO Enlarged Board of Appeal Raises Bar for Challenging Priority Claims at the EPO 

Texas Patent Litigation Monthly Wrap-Up: October 2023

District of Delaware Finds Non-Orange Book-Listed Patents Subject to the Same Pleading Standard as Listed Patents in ANDA Infringement Suit